Philippe A. Tessier

Philippe A. Tessier

Auto-generated profile, based on publicly available information

Philippe A. Tessier

Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Quebec-Universite Laval, Quebec, QC, Canada, Departement de Microbiologie-Infectiologie et d Immunologie, Faculte de Medecine, Universite Laval, Quebec, QC, Canada

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2003 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
CRCarle Ryckman
Carle Ryckman
KVKaren Vandal
Karen Vandal
PRPascal Rouleau
Pascal Rouleau
MTMarièvE Talbot
MarièvE Talbot
PTPhilippe A Tessier
Philippe A Tessier
S100A8 and S100A9 are small calcium-binding proteins that are highly expressed in neutrophil and monocyte cytosol and are found at high levels in the extracellular milieu during inflammatory conditions. Although reports have proposed a proinflammatory role for these proteins, their extracellular activity remains controversial. In this study, we report that S100A8, S100A9, and S100A8/A9 caused neutrophil chemotaxis at concentrations of 10−12–10−9 M. S100A8, S100A9, and S100A8/A9 stimulated shedding of L-selectin, up-regulated and activated Mac-1, and induced neutrophil adhesion to fibrinogen in vitro. Neutralization with Ab showed that this adhesion was mediated by Mac-1. Neutrophil adhesion was also associated with an increase in intracellular calcium levels. However, neutrophil activation by S100A8, S100A9, and S100A8/A9 did not induce actin polymerization. Finally, injection of S100A8, S100A9, or S100A8/A9 into a murine air pouch model led to rapid, transient accumulation of neutrophils confirming their activities in vivo. These studies 1) show that S100A8, S100A9, and S100A8/A9 are potent stimulators of neutrophils and 2) strongly suggest that these proteins are involved in neutrophil migration to inflammatory sites.

8 June 2012 in Science
Verified
Journal Article
Closed access
PDF file
GSGregory F. Sonnenberg
Gregory F. Sonnenberg
LMLaurel A. Monticelli
Laurel A. Monticelli
TATheresa Alenghat
Theresa Alenghat
TFThomas C. Fung
Thomas C. Fung
NHNatalie A. Hutnick
Natalie A. Hutnick
DADavid Artis
David Artis
Protecting Against a Barrier Breach: In order to coexist peacefully, a “firewall” exists that keeps the commensal bacteria that reside in our intestines and associated lymphoid tissue contained. Several diseases and infections, however, lead to a breach in this barrier, which leads to chronic inflammation and pathology. Sonnenberg et al. (p. 1321 ) found that in mice, innate lymphoid cells (ILCs) are critically important for the anatomical containment of commensal bacteria in an interleukin-22 (IL-22)–dependent manner. ILC depletion or blockade of IL-22 led to loss of bacterial containment and systemic inflammation.

11 May 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
MPMarc Parisien
Marc Parisien
LLLucas V. Lima
Lucas V. Lima
CDConcetta Dagostino
Concetta Dagostino
NENehme El-Hachem
Nehme El-Hachem
GDGillian L. Drury
Gillian L. Drury
LDLuda Diatchenko
Luda Diatchenko
The transition from acute to chronic pain is critically important but not well understood. Here, we investigated the pathophysiological mechanisms underlying the transition from acute to chronic low back pain (LBP) and performed transcriptome-wide analysis in peripheral immune cells of 98 participants with acute LBP, followed for 3 months. Transcriptomic changes were compared between patients whose LBP was resolved at 3 months with those whose LBP persisted. We found thousands of dynamic transcriptional changes over 3 months in LBP participants with resolved pain but none in those with persistent pain. Transient neutrophil-driven up-regulation of inflammatory responses was protective against the transition to chronic pain. In mouse pain assays, early treatment with a steroid or nonsteroidal anti-inflammatory drug (NSAID) also led to prolonged pain despite being analgesic in the short term; such a prolongation was not observed with other analgesics. Depletion of neutrophils delayed resolution of pain in mice, whereas peripheral injection of neutrophils themselves, or S100A8/A9 proteins normally released by neutrophils, prevented the development of long-lasting pain induced by an anti-inflammatory drug. Analysis of pain trajectories of human subjects reporting acute back pain in the UK Biobank identified elevated risk of pain persistence for subjects taking NSAIDs. Thus, despite analgesic efficacy at early time points, the management of acute inflammation may be counterproductive for long-term outcomes of LBP sufferers.

19 August 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJean-Christophe Simard
Jean-Christophe Simard
ACAnnabelle Cesaro
Annabelle Cesaro
JCJulie Chapeton-Montes
Julie Chapeton-Montes
MTMélanie Tardif
Mélanie Tardif
FAFrancis Antoine
Francis Antoine
PTPhilippe A. Tessier
Philippe A. Tessier
S100A8 and S100A9 are cytoplasmic proteins expressed by phagocytes. High concentrations of these proteins have been correlated with various inflammatory conditions, including autoimmune diseases such as rheumatoid arthritis and Crohn’s disease, as well as autoinflammatory diseases. In the present study, we examined the effects of S100A8 and S100A9 on the secretion of cytokines and chemokines from PBMCs. S100A8 and S100A9 induced the secretion of cytokines such as IL-6, IL-8, and IL-1β. This secretion was associated with the activation and translocation of the transcription factor NF-κB. Inhibition studies using antisense RNA and the pharmacological agent BAY-117082 confirmed the involvement of NF-κB in IL-6, IL-8, and IL-1β secretion. S100A8- and S100A9-mediated activation of NF-κB, the NLR family, pyrin domain-containing 3 (NLRP3) protein, and pro-IL-1β expression was dependent on the generation of reactive oxygen species. This effect was synergistically enhanced by ATP, a known inflammasome activator. These results suggest that S100A8 and S100A9 enhance the inflammatory response by inducing cytokine secretion of PBMCs.

15 February 2019 in Cancer Research
Verified
Journal Article
Closed access
PDF file
HJHoibin Jeong
Hoibin Jeong
SKSehui Kim
Sehui Kim
BHBeom-Ju Hong
Beom-Ju Hong
CLChan-Ju Lee
Chan-Ju Lee
YKYoung-Eun Kim
Young-Eun Kim
GAG-One Ahn
G-One Ahn
Tumor hypoxia and aerobic glycolysis are well-known resistance factors for anticancer therapies. Here, we demonstrate that tumor-associated macrophages (TAM) enhance tumor hypoxia and aerobic glycolysis in mice subcutaneous tumors and in patients with non–small cell lung cancer (NSCLC). We found a strong correlation between CD68 TAM immunostaining and PET 18fluoro-deoxyglucose (FDG) uptake in 98 matched tumors of patients with NSCLC. We also observed a significant correlation between CD68 and glycolytic gene signatures in 513 patients with NSCLC from The Cancer Genome Atlas database. TAM secreted TNFα to promote tumor cell glycolysis, whereas increased AMP-activated protein kinase and peroxisome proliferator-activated receptor gamma coactivator 1-alpha in TAM facilitated tumor hypoxia. Depletion of TAM by clodronate was sufficient to abrogate aerobic glycolysis and tumor hypoxia, thereby improving tumor response to anticancer therapies. TAM depletion led to a significant increase in programmed death-ligand 1 (PD-L1) expression in aerobic cancer cells as well as T-cell infiltration in tumors, resulting in antitumor efficacy by PD-L1 antibodies, which were otherwise completely ineffective. These data suggest that TAM can significantly alter tumor metabolism, further complicating tumor response to anticancer therapies, including immunotherapy. Significance: These findings show that tumor-associated macrophages can significantly modulate tumor metabolism, hindering the efficacy of anticancer therapies, including anti-PD-L1 immunotherapy.

15 January 2006 in Experimental Cell Research
Verified
Journal Article
Closed access
AHA Hermani
A Hermani
BDB Deservi
B Deservi
SMS Medunjanin
S Medunjanin
PTP Tessier
P Tessier
DMD Mayer
D Mayer